Strategy to 2020 has been a plan for organizational transformation. The Governing Board and Senior Management Team feel the next plan should focus on fewer, prioritized Objectives; a proposed set of 12, down from the current 28.
The Objectives will both reflect and reinforce strategic choice-making and prioritization:
GOAL 1: Producing trusted evidence |
GOAL 2: Informing health decisions |
RELEVANT TRUSTED EVIDENCE UPDATED EFFICIENT |
USABLE ACCESSIBLE LANGUAGE & MULTI-LINGUAL IMPROVE OUR REACH AND IMPACT |
GOAL 3: Advocating for evidence |
GOAL 4: Collaborating effectively |
ADVANCE EVIDENCE-INFORMED DECISION-MAKING IMPROVE EVIDENCE QUALITY |
GLOBAL AND DIVERSE INVESTING IN OUR PEOPLE SUSTAINABLE FINANCIAL MODEL |
You can read more about the rationale for these Objectives, here. This document also provides a sample set of activities against each Objective for 2021 onwards, developed by the Senior Management Team. These activities would be led by the Central Executive Team in collaboration with Cochrane Groups. The idea is that Cochrane Groups also develop activities that will meet the Objectives through their own workplans, in a format and with the timelines that suits their dual accountability to Cochrane and their funders.
In the new framework there are no proposed Objectives on Environmental Sustainability or Partnerships. Instead, these areas will form a lens and measurement across multiple Objectives and support all four Goals. The Board and Senior Management Team feel greater impact against them will be achieved in this way.